AngioDynamics (NASDAQ: ANGO) reported Q3 EPS of $0.02, $0.04 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $71.2 million versus the consensus estimate of $68.95 million.

GUIDANCE:

AngioDynamics sees FY2021 EPS of $0.04-$0.06, versus the consensus of $0.01. AngioDynamics sees FY2021 revenue of $285-288 million, versus the consensus of $283.5 million.

For earnings history and earnings-related data on AngioDynamics (ANGO) click here.